EFFICIENCY OF COMBINED THERAPY BY VALZ AND ESCORDI
COR IN PATIENTS WITH ARTERIAL HYPERTENSION

Burmistrova Larisa Fedorovna, Candidate of medical sciences, associate professor, sub-department of internal diseases, Medical Institute, Penza State University(Penza, 40 Krasnaya str.), lamax-69@mail.ru
Rakhmatullov Fagim Kasymovich, Doctor of medical sciences, professor, head of sub-department of internal diseases, Medical Institute, Penza State University (Penza, 40 Krasnaya str.), pgu-vb2004@mail.ru
Shibaeva Tat'yana Mikhaylovna, Candidate of medical sciences, associate professor, sub-department of internal diseases, Medical Institute, Penza State University(Penza, 40 Krasnaya str.), mr.sanita@yndex.ru
Sisina Ol'ga Nikolaevna, Candidate of medical sciences, head of sub-department of nephrology, Penza Insitute of Advanced Medical Studies(Penza, 8a Stasova str.), olga nicolaevna58@bk.ru
Karelina Anna Alekseevna, Clinical ordinator, sub-department of internal diseases, Medical Institute, Penza State University(Penza, 40 Krasnaya str.), a.carelina2011@yndex.ru

616.12-008.331.1-08-036.868-039.57

The article analyzes the hypotensive efficiency, tolerability and renoprotective effect of angiotensin receptor blocker/dihydropyridine calcium channel blocker combination therapy in 53 patients with moderate arterial hypertension (AH). The work also describes the way the combined therapy influences cardiac structure and function. In initial state and during the combined therapy the patients underwent di-urnal arterial pressure monitoring and Doppler echocardiography; also, their glome-rular filtration rate (GFR) was determined. The findings suggest that the combined therapy is highly effective and tolerable in hypertensive patients receiving long-term treatment.

dihydropyridine calcium channel blockers, angiotensin receptor blockers, arterial hypertension, Escordi Cor, Valz, renoprotection, microalbuminuria.

1. Diagnostika i lecheniye arterial'noy gipertenzii. Rossiyskiye natsional'nyye rekomendatsii VNOK. – M., 2008.
2. Martsevich, S. YU. Antagonisty kal'tsiya: vybor terapii pri arterial'noy gi-pertonii / S. YU. Martsevich // Arterial'naya gipertenziya. – 2004. – № 4. – S. 193–198.
3. Chazova, I. Ye. Kombinirovannaya terapiya bol'nykh arterial'noy gipertoniyey. Metodicheskoye pis'mo/ I.Ye.Chazova, S. A. Boytsov, O. D. Ostroumova. – M., 2004.
4. Karpov, YU. A. Farmakoterapiya v kardiologii: pozitsii antagonistov kal'tsiya / YU. A. Karpov, Ye. V. Sorokin // Consilium Medicum. – 2004. – T. 6, № 5. – P. 330–333.
5. Mukhin, N. A. Kardiorenal'nyye sootnosheniya i risk serdechno-sosudistykh zabole-vaniy / N. A. Mukhin, V.S.Moiseyev // Vestnik RAMN. – 2003. – № 11. – S. 50–55.
6. Tuorailchto, J. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trails Investigators / J. Tuorailchto, D. Rastenyte, W. Birkcnhager [et al.] // N. Engl J. Med. – 1999. – Vol. 340. – P. 677–684.
7. Danlof, D. Cardiovascular morbidity and mortality in the losartan intervention for End-point reduction in hypertension study (LIFE) / D. Danlof, R. Devereux, S. Kjeldsen // Lancet. – 2002. – Vol. 359. – P. 995–1003.
8. Devereux, R. Echocardiography assessment of left ventricular mass in man. Ana-tomic validation of the method / R. Devereux, N. Reichek // Circulation. – 1977. – Vol. 55. – P. 613–618.
9. Celis, H. Antihypertensive therapy in older patients with isolated systolic hyperten-sion: the Syst-Euc experience in general practice / H. Celis, Y. Yodfat, L. Thijs [et al.] // Fam. Pract. – 1996. – Vol. 13. – P. 138–143.
10. Staessen, J. Randomised double-blind com¬parison of placebo and active treatment for older patients with isolated systolic hypertension/J. Staessen, R. Fagard, L.Thijs [et al.] // Lancet. –1998. –Vol. 351. – P. 1755–1762.